Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
To explore the biology of lung adenocarcinoma (LUAD) and identify new therapeutic opportunities, we performed comprehensive proteogenomic characterization of 110 tumors and 101 matched normal adjacent tissues (NATs) incorporating genomics, epigenomics, deep-scale proteomics, phosphoproteomics, and acetylproteomics. Multi-omics clustering revealed four subgroups defined by key driver mutations, country, and gender. Proteomic and phosphoproteomic data illuminated biology downstream of copy number aberrations, somatic mutations, and fusions and identified therapeutic vulnerabilities associated with driver events involving KRAS, EGFR, and ALK. Immune subtyping revealed a complex landscape, reinforced the association of STK11 with immune-cold behavior, and underscored a potential immunosuppressive role of neutrophil degranulation. Smoking-associated LUADs showed correlation with other environmental exposure signatures and a field effect in NATs. Matched NATs allowed identification of differentially expressed proteins with potential diagnostic and therapeutic utility. This proteogenomics dataset represents a unique public resource for researchers and clinicians seeking to better understand and treat lung adenocarcinomas.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373300 | PMC |
| http://dx.doi.org/10.1016/j.cell.2020.06.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficient candidate drug target discovery through proteogenomics in a Scottish cohort.
Commun Biol
August 2025
Centre for Global Health Research, Usher Institute, University of Edinburgh, 5-7 Little France Road, Edinburgh, UK.
Understanding the genomic basis of human proteomic variability provides powerful tools to probe potential causal relationships of proteins and disease risk, and thus to prioritise candidate drug targets. Here, we investigated 6432 plasma proteins (1533 previously unstudied in large-scale proteomic GWAS) using the SomaLogic (v4.1) aptamer-based technology in a Scottish population from the Viking Genes study.
View Article and Find Full Text PDFConvergence: Multi-omics and AI are reshaping the landscape biomedical research.
Biochim Biophys Acta Mol Basis Dis
August 2025
Department of Human Anatomy and Cell Science, University of Manitoba College of Medicine, Winnipeg, Manitoba, Canada; Paul Albrechtsen Research Institute, CancerCare Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada; Akademia Śląska, Katowice, Poland; Children Hospital Research Institut
This special volume of Biochimica et Biophysica Acta - Molecular Basis of Disease showcases a transformative era in biomedical research, driven by the convergence of multi-omics technologies, artificial intelligence (AI), and systems biology. The volume is focused across eight thematic sections-spanning cancer, inflammatory and infectious diseases, neurodegeneration, cardiovascular health, autophagy, respiratory disease, and heme biology-this volume highlights how integrative methodologies are helping to simplify the complexity of disease mechanisms. These studies discuss not only biomarker discovery and disease mechanisms, but also how redox biology, lipidomics, machine learning, and proteogenomics are redefining pathophysiological frameworks.
View Article and Find Full Text PDFhitchhikes on gliding colonies of .
ISME Commun
January 2025
Sustainable and Bio-inspired Materials, Max Planck Institute of Colloids and Interfaces, Potsdam 14476, Germany.
Interspecies interactions shape microbial communities; this is central for microbial ecology. PlyA2 is a marine flavobacterium, which glides over surfaces and forms ordered, structurally coloured colonies, which display angle-dependent reflection of light. SW is an apparently nonmotile, nonstructurally coloured marine bacterium.
View Article and Find Full Text PDFIdentification of Cancer-Associated Proteins in Colorectal Cancer Using Mass Spectrometry.
Proteomes
August 2025
Department of Patient-Derived Cancer Model, Tochigi Cancer Center Research Institute, 4-9-13 Yohnan, Utsunomiya 320-0834, Tochigi, Japan.
Background: Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide, with a multifactorial etiology involving genetic and environmental factors. Advanced proteomics offers valuable insights into the molecular mechanisms of cancer, identifying proteins that function as mediators in tumor biology.
Methods: In this study, we used mass spectrometry-based data-independent acquisition (DIA) to analyze the proteomic landscape of CRC.
Integrated multi-omics characterization across clinically relevant subgroups of long COVID.
Natl Sci Rev
August 2025
Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200040, China.
When SARS-CoV-2 became regional epidemics, a substantial number of patients suffered from post-acute sequelae of COVID-19 (PASC, aka long COVID). Exploring the pathogenesis and especially the heterogenicity features of long COVID subgroups is of paramount importance for understanding its etiology. In this study, through integrative multi-omics analyses encompassing transcriptomics, proteomics, and metabolomics, long COVID patients exhibited overall elevated MAPK pathway activation, while patients who have recovered from long COVID showed down-regulation of this response.
View Article and Find Full Text PDF